Ask AI
ProCE Banner Activity

Are We Treating HBV Early Enough?

Slideset

Download this slideset featuring expert perspectives on expanded HBV treatment candidacy for early treatment engagement, including adverse event considerations, cost-effectiveness, and clinical outcomes such as the potential impact on liver disease progression and HCC rates.

Released: February 23, 2024

Share

Provided by

Provided by Clinical Care Options, LLC, in partnership with Hepatitis B Foundation

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

Hepatitis B Foundation

ProCE Banner